IDH1 and astrocytoma (excluding glioblastoma): However, the most recent WHO classification of astrocytomas considers molecular characteristics that are representative within astrocytomas and this new classification of astrocytomas separates these tumors according to the status of enzyme isocitrate dehydrogenase (IDH): wildtype (IDHwt) or mutant (IDHmt) [2].